Decision path
Use the guide as a safety framework.
Learn the framework first, then check risk, vendor documentation, and personal fit before choosing a compound path.
01
Learn the framework
02
Check risk
03
Take the quiz
04
Compare vendors
Guide next step
Use the guide before choosing a compound.
Take the quiz after this guide so the next page reflects your goal, risk tolerance, and monitoring comfort.
Why this matters
COAs are one of the few concrete pieces of evidence most shoppers can inspect for themselves.
A product page can mention lab testing without giving enough detail to prove anything meaningful.
Users need help separating real documentation from decorative documentation.
Key takeaways
A COA is helpful only when it is specific, recent, and connected to a real lot or batch.
Purity alone is not the whole story. Identity, method, date, and lab traceability matter too.
A screenshot with no batch number or method context should lower confidence, not raise it.
Third-party lab context is usually more persuasive than vague self-issued claims.
Guide protocol path
Use this framework before turning research into a protocol.
- 1
Baseline
Clarify goal, labs, contraindications, and sport/testing status.
- 2
Choose
Pick one primary compound path before stacking extras.
- 3
Source
Check vendor documentation, COA fit, and route constraints.
- 4
Monitor
Track outcomes, adverse effects, and stop conditions.
- 5
Reassess
Review whether the protocol still fits after the first cycle.
COA visual
How to read a COA before trusting a vendor
Example certificate
Product purity and identity report
Batch ID
Must match the exact product page or vial label.
Purity
Look for a numeric purity result, not only 'lab tested' language.
Method
HPLC is common for purity; MS helps confirm identity.
Date
Recent tests are more useful than stale or reused reports.
Red flags
Missing batch, cropped lab name, or generic PDF should slow the purchase.
The fields that matter most
What common methods tell you
| Method | What it helps with | What it does not solve by itself |
|---|---|---|
| HPLC | Purity profiling | Does not fully replace identity confirmation or contamination screening. |
| Mass spectrometry | Identity support and mass confirmation | Does not automatically prove a clean finished product by itself. |
| Endotoxin testing | Bioburden-related risk signal | Only one part of a larger quality picture. |
Red flags worth treating seriously
No clear lot number or batch reference.
No method named, just a purity claim.
Old documents reused across multiple supposedly current listings.
COA image is too cropped, low-resolution, or disconnected from the product variant being sold.
Do not confuse visibility with rigor
A visible COA is better than no documentation, but a weak COA should still lower your confidence.
Frequently asked questions
No. You still want batch linkage, method context, recency, and ideally broader quality evidence around the listing.
Third-party testing usually carries more weight, but only if the report is specific, readable, and tied to the actual product variant.
Sources and review notes
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks - U.S. Food and Drug Administration - accessed 2026-05-15
Used for FDA compounding-risk context and peptide safety flags.
- The Prohibited List - World Anti-Doping Agency - accessed 2026-05-15
Used for athlete-facing WADA risk and peptide-class restrictions.
- Peptide therapeutics: current status and future directions - PubMed / Nature Reviews Drug Discovery - accessed 2026-05-15
Used for broad peptide-therapeutics background and evidence framing.
Use these guides to build confidence first — then compare compounds, review vendor documentation, and take the quiz when you're ready for a plan.